BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33174015)

  • 1. [Retracted] Epigenetic silencing of miR‑130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling.
    Gao F; Wang FG; Liu RR; Xue F; Zhang J; Xu GQ; Bi JH; Meng Z; Huo R
    Int J Oncol; 2020 Dec; 57(6):1383. PubMed ID: 33174015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retracted] Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway.
    Zhang L; Liang X; Li Y
    Oncol Rep; 2021 Jan; 45(1):407. PubMed ID: 33416130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retracted] The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma.
    Fan FY; Deng R; Yi H; Sun HP; Zeng Y; He GC; Su Y
    Int J Oncol; 2021 Feb; 58(2):275. PubMed ID: 33491757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retracted] HNF1A‑AS1 promotes growth and metastasis of esophageal squamous cell carcinoma by sponging miR‑214 to upregulate the expression of SOX-4.
    Wang G; Zhao W; Gao X; Zhang D; Li Y; Zhang Y; Li W
    Int J Oncol; 2021 Mar; 58(3):421. PubMed ID: 33432369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retracted] H19 promotes the migration and invasion of colon cancer by sponging miR‑138 to upregulate the expression of HMGA1.
    Yang Q; Wang X; Tang C; Chen X; He J
    Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33864662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retracted] MicroRNA‑107 inhibits tumor growth and metastasis by targeting the BDNF‑mediated PI3K/AKT pathway in human non‑small lung cancer.
    Xia H; Li Y; Lv X
    Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34278461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retracted] miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma.
    Liu K; Liu S; Zhang W; Ji B; Wang Y; Liu Y
    Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34726253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retracted] MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
    Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
    Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35642668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retracted] MicroRNA‑664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma.
    Wang Q; Wang J; Niu S; Wang S; Liu Y; Wang X
    Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35674174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
    Qu Y; Xia P; Zhang S; Pan S; Zhao J
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34726252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retracted] MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2.
    Li J; Yuan J; Yuan X; Zhao J; Zhang Z; Weng L; Liu J
    Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34278467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retracted] miRNA‑1207‑5p is associated with cancer progression by targeting stomatin‑like protein 2 in esophageal carcinoma.
    Yang X; Zang W; Xuan X; Wang Z; Liu Z; Wang J; Cui J; Zhao G
    Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36562357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retracted] MicroRNA‑154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.
    Zhou H; Zhang M; Yuan H; Zheng W; Meng C; Zhao D
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retracted] miR‑338‑3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2.
    Wen C; Liu X; Ma H; Zhang W; Li H
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retracted] Downregulation of microRNA‑629‑5p in colorectal cancer and prevention of the malignant phenotype by direct targeting of low‑density lipoprotein receptor‑related protein 6.
    Yan G; Li C; Zhao Y; Yue M; Wang L
    Int J Mol Med; 2022 Jan; 49(1):. PubMed ID: 34726250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retracted] miR‑138 inhibits gastric cancer growth by suppressing SOX4.
    Pang L; Li B; Zheng B; Niu L; Ge L
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35014683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retracted] Long noncoding RNA
    Sun X; Shen H; Liu S; Gao J; Zhang S
    Int J Mol Med; 2022 May; 49(5):. PubMed ID: 35322858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retracted] MicroRNA‑18b inhibits the growth of malignant melanoma via inhibition of HIF‑1α‑mediated glycolysis.
    Chen Y; Zhang Z; Luo C; Chen Z; Zhou J
    Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34368877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retracted] MicroRNA‑485 plays tumour‑suppressive roles in colorectal cancer by directly targeting GAB2.
    Li J; Xu J; Yan X; Jin K; Li W; Zhang R
    Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35088894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retracted] miR‑124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3.
    Liu S; Hu C; Wang Y; Shi G; Li Y; Wu H
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34558651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.